Form D · Other

BioIQ, Inc.

Atlanta, GA · CIK 0001530880

Offering snapshot reported Nov 25, 2019 · SEC filing

Reported sold
$14M
Offering amount: $14M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 26, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 25, 2019Initial$14,001,153No comparison12SEC filing
Apr 10, 2018Initial$26,499,990No comparison7SEC filing
Dec 14, 2016Initial$7,067,331No comparison21SEC filing
May 16, 2016Amendment$10,000,000$8,800,000vs Jun 12, 201550SEC filing
Jun 12, 2015Initial$1,200,000No comparison4SEC filing
Oct 5, 2011InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Option to acquire, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-354106
Series H Financing ; Series G-1 Exchange
Exchange of Series G to G 1 Preferred

Source: Form D, filed Nov 25, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Justin Bellante Director, Executive
Brandon Cady Director
Jeff Closs Director
Mike Cotton Director
Todd Creech Director
Patrick Cua Director
Pete Desai Executive
Steven Levin Director
Paul Mc Creadie Director
Andrew Midler Director
Brent Peus Executive
Kathleen Shanahan Director
Jason Torres Director

Issuer details

Industry: Other (See others in industry)

Address:
2300 Windy Ridge Parkway Suite 850 South
Atlanta, GA, 30339